摘要
Background: Acute liver injury (ALI) is a common side effect of cisplatin treatment in the clinic and can lead to liver failure if not treated promptly. Previous studies have revealed that Limonin, a critical bioactive substance in citrus fruits, can protect multiple organs from various medical conditions. However, whether Limonin could ameliorate cisplatin-induced ALI remains unclear.Methods: In vivo and in vitro models were induced by cisplatin in the present study. Non-targeted metabolomics was employed to analyze the metabolic changes in the liver after ALI. In addition, molecular docking was utilized to predict the potential targets of Limonin. Results: Limonin attenuated hepatic histopathological injury by reducing hepatocyte apoptosis, lipid peroxidation, and inflammation in cisplatin-challenged mice. Employing metabolomics, we revealed that Limonin mediated the balance of various disturbed metabolic pathways in the liver after cisplatin-induced ALI. Integrating public data mining, molecular docking studies, and in vitro experiments demonstrated that Limonin suppressed the expression and activity of its direct target, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), in the liver, thus reducing the production of corticosterone (CORT), a key metabolite promoted hepatocyte apoptosis. Conclusions: Limonin improves the liver metabolic microenvironment by inhibiting 11 beta-HSD1 to protect against cisplatin-induced ALI.
学科与关键词
- Limonin mitigates cisplatin-induced acute kidney injury through metabolic reprogrammingZeng, Xi; Zhou, Xianke; Zhou, Jiayi; Zhou, Hong; Hong, Xue; Li, Dier; Xiang, Yadie; Zhong, Menghua; Chen, Yudan; Liang, Dongning; Fu, Haiyan*Biomedicine and Pharmacotherapy, 2023, 167: 115531.
- Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative StressLi, Yunjia; Yang, Menghan; Lin, Haiyan; Yan, Weixin; Deng, Guanghui; Ye, Haixin; Shi, Hao; Wu, Chaofeng; Ma, Guoliang; Xu, Shu; Tan, Qinxiang*; Gao, Zhuowei*; Gao, Lei*Frontiers in Pharmacology, 2022, 12: 801730.被引 11
- DIOSMETIN PROTECTS AGAINST THE CCL4INDUCED ACUTE LIVER INJURY BY ITS ANTIOXIDANT STRESS AND REGULATION ON SIRT6/NF-κB SIGNALING PATHWAYMEDIATED INFLAMMATION IN MICESu, Ye; Zhang, Chunlei7th International Conference on Biomedical Engineering and Pharmaceutical Sciences (ICBEPS), Singapore, SINGAPORE, 2022-06-21 To 2022-06-22.
